Address
Forbion Capital Partners
2-35 Gooimeer
1411 DC Naarden
Netherlands
Phone
Website
Recent investment activity
KANDO id: 21142
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Forbion Capital Fund Ill | Venture | 2015 | USD | 214,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 21 of 21| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
AM-Pharma Holding BV | N/A | ||||
|
|
Amakem NV | N/A | ||||
|
|
arGEN-X BV | Innovation-driven biopharmaceutical company. | Series A | |||
|
|
Argos Therapeutics Inc | Series D | ||||
|
|
Argos Therapeutics Inc | Series C | ||||
|
|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series D | |||
|
|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Venture | |||
|
|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series B | |||
|
|
CircuLite Inc | Develops superficially implanted ventricular assist devices. | Series D | |||
|
|
CircuLite Inc | Develops superficially implanted ventricular assist devices. | Series C | |||
|
|
Mitralign Inc | Percutaneous mitral valve repair system. | Series D | |||
|
|
Mitralign Inc | Percutaneous mitral valve repair system. | Series C | |||
|
|
Pathway Medical Technologies Inc | Manufacturer of medical devices for the treatment of arterial disease. | Series D | |||
|
|
Pathway Medical Technologies Inc | Manufacturer of medical devices for the treatment of arterial disease. | Series C | |||
|
|
PneumRx Inc | Developer of minimally invasive treatments for emphysema patients. | N/A | |||
|
|
Promedior Inc | A biotechnology company developing novel biologic therapeutics to treat fibroproliferative diseases. | Series C | |||
|
|
Santaris Pharma AS | Venture | ||||
|
|
Transave Inc | N/A | ||||
|
|
Allecra Therapeutics | Developer of antibiotic treatments designed to combat multi drug-resistant gram-negative bacteria | Series A Co-led the round. | |||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series F | |||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series E |